Viewing Study NCT03434769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-02-08 @ 6:17 AM
Study NCT ID: NCT03434769
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-06
First Post: 2018-02-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
Sponsor: Benjamin Tomlinson
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cyclophosphamide View
None Fludarabine View
None Chimeric antigen receptor T cells View